The Society Prize is a global recognition that is awarded annually to a researcher, physician, or team lead who has made a positive and lasting impact in the fight against paediatric cancer.
The award is accompanied with a $25,000 cash prize.
Professor Gilbertson was selected as this year’s recipient for his contributions and discoveries that have impacted children with cancer including the developmental origins of childhood brain tumours that have led not only to an understanding of the molecular and cellular origins of these tumours, but which have also impacted clinical outcomes through risk stratified treatments and new targeted therapeutic options.
Founded in 1946, The Society of Memorial Sloan Kettering is a volunteer-led organisation within MSK dedicated to promoting the well-being of patients, supporting cancer research, and providing education on the early prevention, detection, and treatment of cancer.
“It is both exciting and humbling to be honored with this recognition,” said Professor Gilbertson whose research group is based in the CRUK Cambridge Institute. “I share this award with all my amazing colleagues and collaborators – including countless patients and their families – who together work daily to ensure cancer is no longer a leading cause of death by disease among children across the world.”
“The Society of Memorial Sloan Kettering Prize recognises individuals who have made extraordinary contributions to improving outcomes for children with cancer,” said Dr. Andrew Kung, MD, PhD, Chair of the Department of Paediatrics at MSK Kids. “Professor Gilbertson has made many significant discoveries over the years that have improved the way we as clinicians treat children with brain tumours. We are delighted to honour Professor Gilbertson and I can think of no one more deserving of joining the luminaries who have been honoured with this Prize.”